CNS PHARMACEUTICALS, INC. (CNSP): Price and Financial Metrics
CNSP Price/Volume Stats
| Current price | $0.12 | 52-week high | $135.00 |
| Prev. close | $0.13 | 52-week low | $0.10 |
| Day low | $0.11 | Volume | 8,049,300 |
| Day high | $0.14 | Avg. volume | 5,564,283 |
| 50-day MA | $0.13 | Dividend yield | N/A |
| 200-day MA | $5.98 | Market Cap | 4.13M |
CNSP Stock Price Chart Interactive Chart >
CNS PHARMACEUTICALS, INC. (CNSP) Company Bio
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
CNSP Price Returns
| 1-mo | -23.42% |
| 3-mo | -38.46% |
| 6-mo | -98.85% |
| 1-year | -99.89% |
| 3-year | -99.99% |
| 5-year | -100.00% |
| YTD | -99.81% |
| 2023 | -47.08% |
| 2022 | -88.61% |
| 2021 | -60.54% |
| 2020 | -54.94% |
| 2019 | N/A |
Loading social stream, please wait...